Digitalization enables sustainable pharma plant design

June 24, 2024

Remove from favorites

Add to favorites

The pharmaceutical sector is increasingly aware of the need for sustainable manufacturing, particularly given its high CO2 emissions, surpassing even the automotive sector. Major pharmaceutical companies are investing in eco-friendly practices like renewable energy and waste reduction. However, significant gains are still needed in the design, engineering, and maintenance of manufacturing plants.

Digitalization offers a promising solution by reducing environmental impact and optimizing processes, potentially saving costs and resources. The CPI’s Medicines Manufacturing Innovation Centre, with collaborators like Siemens, GSK, and AstraZeneca, aims to promote sustainable practices and digital solutions across the industry. Technologies like virtual modelling and digital twinning can revolutionize manufacturing by reducing material use, enhancing efficiency, and enabling remote collaboration. Overall, digitalization is key to a greener future for pharmaceutical manufacturing, aligning sustainability with regulatory and commercial goals.